1. Robbins, H. A. et al. Epidemiologic contributions to recent cancer trends among HIV-infected people in the United States. AIDS 28, 881–90 (2014).
2. Shiels, M. S. et al. North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD) of the International Epidemiologic Databases to Evaluate AIDS (leDEA). HIV infection, immunosuppression and age at diagnosis of non-AIDS-defining cancers. Clin Infect Dis 64, 468–75 (2017).
3. Howlader, N. et al. Contributions of HIV to Non-Hodgkin Lymphoma Mortality Trends in the US.[J]. Cancer epidemiology, biomarkers & prevention: a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive. Oncology 25(9), 1289–1296 (2016).
4. Schommers, P. et al. Survival of AIDS-related diffuse large B-cell lymphoma, Burkitt lymphoma, and plasmablastic lymphoma in the German HIV Lymphoma Cohort. Br J Haematol 168, 806–810 (2015).
5. Cobucci, R. N. et al. Assessing the impact of HAART on the incidence of defining and non-defining AIDS cancers among patients with HIV/AIDS: a systematic review [J]. J Infect Public Health 8(1), 1–10 (2015).